453
Views
0
CrossRef citations to date
0
Altmetric
Pregnancy, Childbirth & Women's Health

Comparison of the ED50 of prophylactic butorphanol in preventing morphine-induced pruritus with or without palonosetron: a prospective, double-blinded, randomized dose–response trial using an up-down sequential allocation method

, , , , , & show all
Article: 2304671 | Received 01 Aug 2023, Accepted 02 Jan 2024, Published online: 17 Jan 2024

References

  • Kjellberg F, Tramèr MR. Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur J Anaesthesiol. 2001;18(6):1–9. doi: 10.1046/j.0265-0215.2000.00826.x.
  • Sharpe EE, Molitor RJ, Arendt KW, et al. Intrathecal morphine versus intrathecal hydromorphone for analgesia after cesarean delivery: a randomized clinical trial. Anesthesiology. 2020;132(6):1382–1391. doi: 10.1097/ALN.0000000000003283.
  • Gehling M, Tryba M. Risks and side-effects of intrathecal morphine combined with spinal anaesthesia: a meta-analysis. Anaesthesia. 2009;64(6):643–651. doi: 10.1111/j.1365-2044.2008.05817.x.
  • Wu Z, Kong M, Wang N, et al. Intravenous butorphanol administration reduces intrathecal morphine-induced pruritus after cesarean delivery: a randomized, double-blind, placebo-controlled study. J Anesth. 2012;26(5):752–757. doi: 10.1007/s00540-012-1421-7.
  • Gunter JB, McAuliffe J, Gregg T, et al. Continuous epidural butorphanol relieves pruritus associated with epidural morphine infusions in children. Paediatr Anaesth. 2000;10(2):167–172. doi: 10.1046/j.1460-9592.2000.00447.x.
  • Yokoyama Y, Yokoyama T, Nagao Y, et al. Treatment of epidural morphine induced pruritus with butorphanol. Masui. 2009;58(2):178–182.
  • Subramani Y, Nagappa M, Kumar K, et al. Medications for the prevention of pruritus in women undergoing cesarean delivery with intrathecal morphine: a systematic review and Bayesian network meta-analysis of randomized controlled trials. J Clin Anesth. 2021;68:110102. doi: 10.1016/j.jclinane.2020.110102.
  • Rashid S, Trivedi DD, Al-Shathir M, et al. Is there a role for 5-HT(3) receptor antagonists in the treatment of opioid-induced pruritus? Am J Hosp Palliat Care. 2018;35(4):740–744. doi: 10.1177/1049909117736062.
  • Bonnet MP, Marret E, Josserand J, et al. Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review. Br J Anaesth. 2008;101(3):311–319. doi: 10.1093/bja/aen202.
  • Yang LP, Scott LJ. Palonosetron: in the prevention of nausea and vomiting. Drugs. 2009;69(16):2257–2278. doi: 10.2165/11200980-000000000-00000.
  • Phan NQ, Blome C, Fritz F, et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol. 2012;92(5):502–507. doi: 10.2340/00015555-1246.
  • Flaherty SA. Pain measurement tools for clinical practice and research. Aana J. 1996;64(2):133–140.
  • Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14(7):798–804. doi: 10.1111/j.1365-2702.2005.01121.x.
  • Ramsay MA, Savege TM, Simpson BR, et al. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2(5920):656–659. doi: 10.1136/bmj.2.5920.656.
  • Pace NL, Stylianou MP. Advances in and limitations of up-and-down methodology: a precis of clinical use, study design, and dose estimation in anesthesia research. Anesthesiology. 2007;107(1):144–152. doi: 10.1097/01.anes.0000267514.42592.2a.
  • Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991;15(1):47–50. doi: 10.1016/s0149-7634(05)80090-9.
  • Dixon WJ, Mood AM. A method for obtaining and analyzing sensitivity data. J Am Stat Assoc. 1948/03/011948;43(241):109–126. doi: 10.1080/01621459.1948.10483254.
  • Desjardins PJ, Norris LH, Cooper SA, et al. Analgesic efficacy of intranasal butorphanol (stadol NS) in the treatment of pain after dental impaction surgery. J Oral Maxillofac Surg. 2000;58(10 Suppl 2):19–26. doi: 10.1053/joms.2000.17884.
  • Benhamou D. Postoperative nausea and vomiting: is the big little problem becoming a smaller little problem? Br J Anaesth. 2023;131(1):22–25. doi: 10.1016/j.bja.2023.04.004.
  • Felden L, Walter C, Harder S, et al. Comparative clinical effects of hydromorphone and morphine: a meta-analysis. Br J Anaesth. 2011;107(3):319–328. doi: 10.1093/bja/aer200.
  • Sultan P, Halpern SH, Pushpanathan E, et al. The effect of intrathecal morphine dose on outcomes after elective cesarean delivery: a meta-analysis. Anesth Analg. 2016;123(1):154–164. doi: 10.1213/ANE.0000000000001255.
  • Kumar K, Singh SI. Neuraxial opioid-induced pruritus: an update. J Anaesthesiol Clin Pharmacol. 2013;29(3):303–307. doi: 10.4103/0970-9185.117045.
  • Yurashevich M, Habib AS. Monitoring, prevention and treatment of side effects of long-acting neuraxial opioids for post-cesarean analgesia. Int J Obstet Anesth. 2019;39:117–128. doi: 10.1016/j.ijoa.2019.03.010.
  • Ko MC. Neuraxial opioid-induced itch and its pharmacological antagonism. Handb Exp Pharmacol. 2015;226:315–335. doi: 10.1007/978-3-662-44605-8_17.
  • Dependence WHOECoD. WHO expert committee on drug dependence. World Health Organ Tech Rep Ser. 2006;i(942): 1. 23-4 passim.
  • Nelson KE, Eisenach JC. Intravenous butorphanol, meperidine, and their combination relieve pain and distress in women in labor. Anesthesiology. 2005;102(5):1008–1013. doi: 10.1097/00000542-200505000-00021.
  • Zhu Z, Zhang W. Efficacy and safety of butorphanol use in patient-controlled analgesia: a meta-analysis. Evid Based Complement Alternat Med. 2021;2021:5530441–5530441. doi: 10.1155/2021/5530441.
  • Rojas C, Thomas AG, Alt J, et al. Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function. Eur J Pharmacol. 2010;626(2-3):193–199. doi: 10.1016/j.ejphar.2009.10.002.
  • Roila F, Del Favero A. Ondansetron clinical pharmacokinetics. Clin Pharmacokinet. 1995;29(2):95–109. doi: 10.2165/00003088-199529020-00004.
  • Chun HR, Jeon IS, Park SY, et al. Efficacy of palonosetron for the prevention of postoperative nausea and vomiting: a randomized, double-blinded, placebo-controlled trial. Br J Anaesth. 2014;112(3):485–490. doi: 10.1093/bja/aet340.
  • Siddiqui MA, Scott LJ. Palonosetron. Drugs. 2004;64(10):1125–1132. doi: 10.2165/00003495-200464100-00006.
  • Wang Y, Zhang Q, Dai X, et al. Effect of low-dose esketamine on pain control and postpartum depression after cesarean section: a retrospective cohort study. Ann Palliat Med. 2022;11(1):45–57. doi: 10.21037/apm-21-3343.
  • Singh SI, Rehou S, Marmai KL, et al. The efficacy of 2 doses of epidural morphine for postcesarean delivery analgesia: a randomized noninferiority trial. Anesth Analg. 2013;117(3):677–685. doi: 10.1213/ANE.0b013e31829cfd21.
  • Chaney MA. Side effects of intrathecal and epidural opioids. Can J Anaesth. 1995;42(10):891–903. doi: 10.1007/BF03011037.